Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-10

Clinical Trial Update: Efficacy of Tart Cherry Juice in Reducing Muscle Injury and Biomarkers of Muscle Damage Among Healthy Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether tart cherry juice reduces muscle injury and biomarkers of muscle damage in healthy adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tart cherry juice

Snippet

Sponsor: Oregon Health and Science University | Conditions: Inflammation, Pain | Phase 4 | Status: COMPLETED